Am. J. Respir. Crit. Care Med., Volume 164, Number 4, August 2001, 669-671

Prevalence and Clinical Characteristics of Lymphangioleiomyomatosis (LAM) in Patients with Tuberous Sclerosis Complex

JOEL MOSS, NILO A. AVILA, PAULINE M. BARNES, RUTH A. LITZENBERGER, JEANMARIE BECHTLE, PAMELA G. BROOKS, CAROLYN J. HEDIN, SALLY HUNSBERGER, and ARNOLD S. KRISTOF

Pulmonary-Critical Care Medicine Branch, National Heart, Lung, and Blood Institute, Diagnostic Radiology Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland

The true prevalence of pulmonary lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex (TSC) is unknown. The prevalence of LAM, radiological features, and lung function in patients with TSC was measured. The presence of LAM, as defined by the presence of cysts by high-resolution chest computed tomography (HRCT) scan, was determined in patients with TSC without prior pulmonary disease (Group 1). To determine the significance of early detection, severity of disease in screened patients (Group 1) was compared with that in patients with TSC with a prior diagnosis of LAM (Group 2). Forty-eight patients with TSC and no prior history of LAM were screened. Of the 38 females, 13 (34%) had LAM; LAM was absent in males. Lung function was preserved in patients with TSC who were found to have LAM by screening. In patients previously known to have LAM, FEV₁ and DL_CO correlated inversely with severity of disease as assessed by CT scan. The prevalence of LAM in women with TSC was 34%, ~ 10-fold that previously reported, consistent with a large hitherto unrecognized subclinical population of patients at risk for pulmonary complications.

Keywords: lymphangioleiomyomatosis; tuberous sclerosis complex; lung function

This article has been cited by other articles:

				C. D. Burger and F. X. McCormack Variability in the Prevalence of Acute Bronchoresponsiveness in Different Populations of Patients With Lymphangioleiomyomatosis Chest, July 1, 2008; 134(1): 217 - 218. [Full Text] [PDF]

				F. X. McCormack Lymphangioleiomyomatosis: A Clinical Update Chest, February 1, 2008; 133(2): 507 - 516. [Abstract] [Full Text] [PDF]

				G. P Cosgrove, S. K Frankel, and K. K Brown Challenges in pulmonary fibrosis {middle dot} 3: Cystic lung disease Thorax, September 1, 2007; 62(9): 820 - 829. [Abstract] [Full Text] [PDF]

				F. X. McCormack and J. Moss S-LAM in a Man? Am. J. Respir. Crit. Care Med., July 1, 2007; 176(1): 3 - 5. [Full Text] [PDF]

				S. C. Juvet, F. X. McCormack, D. J. Kwiatkowski, and G. P. Downey Molecular Pathogenesis of Lymphangioleiomyomatosis: Lessons Learned from Orphans Am. J. Respir. Cell Mol. Biol., April 1, 2007; 36(4): 398 - 408. [Abstract] [Full Text] [PDF]

				N. A. Avila, A. J. Dwyer, A. Rabel, and J. Moss Sporadic Lymphangioleiomyomatosis and Tuberous Sclerosis Complex with Lymphangioleiomyomatosis: Comparison of CT Features Radiology, December 1, 2006; 242(1): 277 - 285. [Abstract] [Full Text] [PDF]

				S. R. Johnson Lymphangioleiomyomatosis. Eur. Respir. J., May 1, 2006; 27(5): 1056 - 1065. [Abstract] [Full Text] [PDF]

				L. R. Young, K. F. Almoosa, S. Pollock-BarZiv, M. Coutinho, F. X. McCormack, and S. A. Sahn Patient Perspectives on Management of Pneumothorax in Lymphangioleiomyomatosis Chest, May 1, 2006; 129(5): 1267 - 1273. [Abstract] [Full Text] [PDF]

				D. J. Kwiatkowski and B. D. Manning Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways Hum. Mol. Genet., October 15, 2005; 14(suppl_2): R251 - R258. [Abstract] [Full Text] [PDF]

				M M Cohen, S Pollock-BarZiv, and S R Johnson Emerging clinical picture of lymphangioleiomyomatosis Thorax, October 1, 2005; 60(10): 875 - 879. [Abstract] [Full Text] [PDF]

				N. El-Hashemite and D. J. Kwiatkowski Interferon-{gamma}-Jak-Stat Signaling in Pulmonary Lymphangioleiomyomatosis and Renal Angiomyolipoma: A Potential Therapeutic Target Am. J. Respir. Cell Mol. Biol., September 1, 2005; 33(3): 227 - 230. [Abstract] [Full Text] [PDF]

				G. F. Abbott, M. L. Rosado-de-Christenson, A. A. Frazier, T. J. Franks, R. D. Pugatch, and J. R. Galvin From the Archives of the AFIP: Lymphangioleiomyomatosis: Radiologic-Pathologic Correlation RadioGraphics, May 1, 2005; 25(3): 803 - 828. [Abstract] [Full Text] [PDF]

				N. El-Hashemite, V. Walker, and D. J. Kwiatkowski Estrogen Enhances whereas Tamoxifen Retards Development of Tsc Mouse Liver Hemangioma: A Tumor Related to Renal Angiomyolipoma and Pulmonary Lymphangioleiomyomatosis Cancer Res., March 15, 2005; 65(6): 2474 - 2481. [Abstract] [Full Text] [PDF]

				A. Astrinidis and E. Petri Henske Aberrant Cellular Differentiation and Migration in Renal and Pulmonary Tuberous Sclerosis Complex J Child Neurol, September 1, 2004; 19(9): 710 - 715. [Abstract] [PDF]

				G. Finlay The LAM cell: what is it, where does it come from, and why does it grow? Am J Physiol Lung Cell Mol Physiol, April 1, 2004; 286(4): L690 - L693. [Full Text] [PDF]

				J. Yu, A. Astrinidis, S. Howard, and E. P. Henske Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways Am J Physiol Lung Cell Mol Physiol, April 1, 2004; 286(4): L694 - L700. [Abstract] [Full Text] [PDF]

				K. E. Sietsema and F. X. McCormack Lymphangioleiomyomatosis: Insights about, and from, a Rare Disease Am. J. Respir. Crit. Care Med., December 15, 2003; 168(12): 1405 - 1406. [Full Text] [PDF]

				G. A. Finlay, D. S. Hunter, C. L. Walker, K. E. Paulson, and B. L. Fanburg Regulation of PDGF production and ERK activation by estrogen is associated with TSC2 gene expression Am J Physiol Cell Physiol, August 1, 2003; 285(2): C409 - C418. [Abstract] [Full Text] [PDF]

				M. Karbowniczek, A. Astrinidis, B. R. Balsara, J. R. Testa, J. H. Lium, T. V. Colby, F. X. McCormack, and E. P. Henske Recurrent Lymphangiomyomatosis after Transplantation: Genetic Analyses Reveal a Metastatic Mechanism Am. J. Respir. Crit. Care Med., April 1, 2003; 167(7): 976 - 982. [Abstract] [Full Text] [PDF]

				E. Pallisa, P. Sanz, A. Roman, J. Majo, J. Andreu, and J. Caceres Lymphangioleiomyomatosis: Pulmonary and Abdominal Findings with Pathologic Correlation RadioGraphics, October 1, 2002; 22(90001): S185 - 198. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Tuberculosis, Lung Infections, Interstitial Lung Disease, and Socioeconomic Issues in AJRCCM 2001 Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 631 - 641. [Full Text] [PDF]

				G. Pacheco-Rodriguez, A. S. Kristof, L. A. Stevens, Y. Zhang, D. Crooks, and J. Moss Genetics and Gene Expression in Lymphangioleiomyomatosis : Giles F. Filley Lecture Chest, March 1, 2002; 121(2007): 56S - 61S. [Abstract] [Full Text] [PDF]

				J. Moss, R. DeCastro, N. J. Patronas, and A. Taveira-DaSilva Meningiomas in Lymphangioleiomyomatosis JAMA, October 17, 2001; 286(15): 1879 - 1881. [Abstract] [Full Text] [PDF]